HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas

<p>Abstract</p> <p>Background</p> <p>Lymphomas frequently retain wild-type (wt) p53 function but overexpress HDM2, thereby compromising p53 activity. Therefore, lymphoma is a suitable model for studying the therapeutic value of disrupting the HDM2-p53 interaction by sma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Sosin Angela M, Burger Angelika M, Siddiqi Aisha, Abrams Judith, Mohammad Ramzi M, Al-Katib Ayad M
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2012-09-01
coleção:Journal of Hematology & Oncology
Assuntos:
HDM2
p53
Apoptosis
MI-219
Nutlin-3
B-cell lymphoma
Small-molecule inhibitor
Autoubiquitination
Acesso em linha:http://www.jhoonline.org/content/5/1/57
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados